Template:Congestive heart failure: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 133: Line 133:
: [[Congestive heart failure overview of treatment#Acute Pharmacotherapy|Acute Pharmacotherapy]]
: [[Congestive heart failure overview of treatment#Acute Pharmacotherapy|Acute Pharmacotherapy]]
: [[Congestive heart failure overview of treatment#Chronic Pharmacotherapy|Chronic Pharmacotherapy]]
: [[Congestive heart failure overview of treatment#Chronic Pharmacotherapy|Chronic Pharmacotherapy]]
:: [[Congestive heart failure diuretics]]
:: [[Congestive heart failure diuretics|Diuretics]]
:: [[Congestive heart failure overview of treatment#Renin-Angiotensin-Aldosterone Axis Inhibitors|Renin-Angiotensin-Aldosterone Axis Inhibitors]]
:: [[Congestive heart failure overview of treatment#Renin-Angiotensin-Aldosterone Axis Inhibitors|Renin-Angiotensin-Aldosterone Axis Inhibitors]]
:: [[Congestive heart failure overview of treatment#Nitrates|Nitrates]]
:: [[Congestive heart failure overview of treatment#Nitrates|Nitrates]]

Revision as of 00:00, 4 April 2012

Congestive heart failure Microchapters

Home

Patient Info

Overview

Classification

Pathophysiology

Epidemiology & Demographics

Risk Factors

Causes of Congestive heart failure

Differentiating Congestive heart failure from other Diseases

Natural History, Complications & Prognosis

Diagnosis

Clinical Assessment

History & Symptoms

Physical Examination

Lab Tests

Electrocardiogram

Chest X Ray

Echocardiography

Other Diagnostic Studies

Treatment

Medical Therapy:

Acute Pharmacotherapy
Chronic Pharmacotherapy
Diuretics
Renin-Angiotensin-Aldosterone Axis Inhibitors
Nitrates
Anticoagulants
Beta Blockers
Antiarrhythmic Drugs
Positive Inotropics
Metformin
Ca Channel Blockers

Surgery:

Biventricular Pacing or Cardiac Resynchronization Therapy (CRT)
Implantation of Intracardiac Defibrillator
Ultrafiltration
Cardiac Surgery
Left Ventricular Assist Devices (LVADs)
Cardiac Transplantation
Invasive Monitoring

Guideline Recommendations

Hospitalized Patients
Patients at high risk for developing heart failure (Stage A)
Patients with cardiac structural abnormalities or remodeling who have not developed heart failure symptoms (Stage B)
Patients with current or prior symptoms of heart failure (Stage C)
Patients with refractory end-stage heart failure (Stage D)

Implementation of Practice Guidelines

Congestive heart failure end-of-life considerations

Specific Groups:

Special Populations
Patients who have concomitant disorders
Obstructive Sleep Apnea in the Patient with CHF

Congestive heart failure On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Congestive heart failure

CDC on Congestive heart failure

Congestive heart failure in the news

Blogs on Congestive heart failure

Directions to Hospitals Treating Congestive heart failure

Risk calculators and risk factors for Congestive heart failure